Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1990 1
1993 1
1994 1
1995 1
1998 1
2002 3
2003 2
2005 2
2006 2
2007 1
2008 1
2009 4
2011 1
2012 3
2013 5
2014 2
2017 1
2018 4
2019 1
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM, Madden SF, Gaynor N, AlSultan D, Le Gal M, Eustace AJ, Gately KA, Hughes C, Davies AM, Mahgoub T, Ballot J, Toomey S, O'Connor DP, Gallagher WM, Holmes FA, Espina V, Liotta L, Hennessy BT, O'Byrne KJ, Hasmann M, Bossenmaier B, O'Donovan N, Crown J. Collins DM, et al. Among authors: hasmann m. Clin Cancer Res. 2021 Feb 1;27(3):807-818. doi: 10.1158/1078-0432.CCR-20-2007. Epub 2020 Oct 29. Clin Cancer Res. 2021. PMID: 33122343
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer.
Cejalvo JM, Jacob W, Fleitas Kanonnikoff T, Felip E, Navarro Mendivil A, Martinez Garcia M, Taus Garcia A, Leighl N, Lassen U, Mau-Soerensen M, Adessi C, Michielin F, James I, Ceppi M, Hasmann M, Weisser M, Cervantes A. Cejalvo JM, et al. Among authors: hasmann m. ESMO Open. 2019 Jul 22;4(4):e000532. doi: 10.1136/esmoopen-2019-000532. eCollection 2019. ESMO Open. 2019. PMID: 31423336 Free PMC article.
Preclinical data for Droloxifene.
Hasmann M, Rattel B, Löser R. Hasmann M, et al. Cancer Lett. 1994 Sep 15;84(2):101-16. doi: 10.1016/0304-3835(94)90364-6. Cancer Lett. 1994. PMID: 8076367 Review.
Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy.
Moisan A, Michielin F, Jacob W, Kronenberg S, Wilson S, Avignon B, Gérard R, Benmansour F, McIntyre C, Meneses-Lorente G, Hasmann M, Schneeweiss A, Weisser M, Adessi C. Moisan A, et al. Among authors: hasmann m. Mol Cancer Ther. 2018 Jul;17(7):1464-1474. doi: 10.1158/1535-7163.MCT-17-1268. Epub 2018 Apr 13. Mol Cancer Ther. 2018. PMID: 29654069 Free article. Clinical Trial.
Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions.
Schmid I, Bonnington L, Gerl M, Bomans K, Thaller AL, Wagner K, Schlothauer T, Falkenstein R, Zimmermann B, Kopitz J, Hasmann M, Bauss F, Haberger M, Reusch D, Bulau P. Schmid I, et al. Among authors: hasmann m. Commun Biol. 2018 Apr 5;1:28. doi: 10.1038/s42003-018-0032-8. eCollection 2018. Commun Biol. 2018. PMID: 30271914 Free PMC article.
40 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page